Price:

SCIENCE

Sinclair warns GLP-1 blindness risk spurs regenerative cure trials

Friday, May 1, 2026 · from 2 podcasts
2 SOURCESThe Joe Rogan ExperienceMoonshots with Peter Diam…
  • David Sinclair targets sudden blindness risk from GLP-1 drugs like Ozempic with new gene therapies.
  • AI now autonomously discovers biology humans miss, like overlooked aging markers.
  • Longevity science pivots as genes dictate half of lifespan, double prior estimates.

David Sinclair is racing to reverse a rare but devastating side effect of blockbuster weight-loss drugs: sudden blindness. On the Moonshots podcast, he detailed a condition called NAION, a form of optic nerve stroke linked to GLP-1 agonists like Ozempic. His lab is now testing a gene therapy, ER100, that uses three transcription factors - OSK - to reset the age of eye cells, aiming to regrow damaged neurons.

This urgency stems from AI-driven discovery. Sinclair described an agentic system named Cadence that analyzed transcriptomic data and identified biological age markers scientists had completely missed. “This isn't just automation; it's a shift in the scientific method where the AI acts as a creative partner,” he said. The lab now uses AI to screen billions of molecules for anti-aging properties, a process Sinclair claims would otherwise take centuries.

"AI can already match or exceed human creativity in scientific hypothesis generation."

- David Sinclair, Moonshots with Peter Diamandis

A foundational assumption in longevity is also cracking. Sinclair cited new data showing genetics may determine 50% of lifespan, doubling the old estimate of 10-15%. Host Peter Diamandis framed the implication: lifestyle dictates health until about age 80, but pushing past that toward 110 is largely gated by genetics. This makes genomic screening a clinical imperative, not a luxury.

The conversation around vision loss extends beyond pharmaceuticals. On The Joe Rogan Experience, host Joe Rogan claimed he reversed his need for reading glasses using red light therapy and a 'macular support' supplement stack vetted by Andrew Huberman. While an anecdote, it underscores a growing public focus on reclaiming lost sensory function through biohacking, setting a market expectation Sinclair’s gene therapy must meet.

"He successfully reversed his dependency on reading glasses using red light therapy and targeted nutrients."

- The Joe Rogan Experience

Sinclair’s pivot places him at a clinical crossroads. He’s moving beyond merely managing a drug side effect to attempting full cellular reversal - a bet that the same tools extending lifespan can also repair acute damage. The success of ER100 could redefine the risk calculus for millions on GLP-1 drugs and prove AI’s role as more than a pattern-finding tool, but a partner in biological innovation.

LongevityHealthAI Infrastructure
Peter Diamandis

Source Intelligence

- Deep dive into what was said in the episodes

The Joe Rogan Experience
The Joe Rogan Experience

#2491 - Brian Simpson • Apr 29

  • Brian Simpson says red light therapy and a macular support supplement eliminated his need for reading glasses, though his vision is still imperfect in low light.
  • Simpson had a heart attack on Super Bowl weekend in Atlanta and received a stent. He joked with the surgeon during the procedure, which she did not appreciate.
  • Cardiothoracic surgeon Dr. Stephen Gundry argues nicotine is a powerful mitochondrial uncoupler and that a high-polyphenol diet can mitigate smoking's damage, citing long-lived smokers in blue zones. Critics strongly dispute this, noting smoking is a leading cause of premature death.
  • A standard cigarette contains 10-14mg of nicotine, but smokers absorb only 1-2mg. Nicotine pouches range from 2mg to 12mg or more per pouch, with absorption being slower but total dose potentially similar.
  • The U.S. cigarette market is worth about $76 billion annually. The oral nicotine market is around $6 billion but is projected to reach $50 billion by 2030.
  • The global nicotine replacement therapy market (patches, gum, lozenges) is valued at $3.1 billion and is predicted to reach $4.7 billion by 2034.
Also from this episode: (12)

Society (4)

  • Simpson's dog Marshall ate pounds of gravel after consuming spilled chicken food, requiring an overnight vet stay. The dog passed the rocks without surgery.
  • Simpson criticizes people who keep large, high-energy dog breeds like Cane Corsos or Blue Heelers in small apartments without providing adequate exercise.
  • Simpson plays the closed beta video game 'Deadlock,' a 6v6 third-person game with 34 characters where players earn in-game currency (Souls) to buy items and snowball advantages. Matches last 25 minutes to an hour.
  • Streamer T-Pain has an elaborate multi-room gaming setup with racing and flight simulators. Simpson speculates top streamers can earn at least $250,000 per month.

Biology (5)

  • Simpson argues wolves cannot be trained, unlike bears, lions, or tigers, citing a friend's escaped wolves that killed a neighbor's sheep.
  • Catnip triggers playful or euphoric behavior in about two-thirds of cats due to the compound nepetalactone, with effects lasting 5 to 15 minutes.
  • Coyotes have expanded into every U.S. state and major city, including New York and Chicago. Their populations increase when pack members go missing, as females have larger litters.
  • A Russian fox domestication experiment over 60 years bred silver foxes for tameness, resulting in dog-like behavior. Domesticated foxes can cost around $9,000.
  • Coastal bears like Kodiak bears grow larger due to access to salmon runs, which provide easy, abundant food. During a run, bears focus solely on salmon and ignore other potential prey.

Psychology (1)

  • Simpson's cat Millie has behavioral issues from a traumatic past with other animals but is affectionate with him. She is difficult to groom and restrain.

Climate (1)

  • Florida's invasive python problem originated from a research facility damaged by a hurricane. Control efforts using robot rabbit lures failed because alligators, the snakes' natural predators, attacked the boxes instead.

Politics (1)

  • Congresswoman Ilhan Omar mistakenly read 'World War II' as 'World War 11' from a script during a hearing, a clip of which circulated online.
LongevityPsychologyBiologyHealth
Moonshots with Peter Diamandis
Moonshots with Peter Diamandis

David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251 • Apr 28

  • David Sinclair says emerging data shows GLP-1 drugs benefit the heart and brain beyond weight loss, but notes a rare but serious side effect: about 20,000-30,000 people in the US annually develop sudden blindness, called NAION.
  • Sinclair states that AI accelerates his lab's work exponentially, enabling drug design by screening billions of molecules and classifying millions of cells as young or old within minutes.
  • Sinclair cites his own father's health as evidence that lifestyle can override poor genetics, noting his Ashkenazi Jewish ancestors typically died in their 70s.
  • Sinclair argues mindset is a powerful longevity factor, citing a National Academy of Sciences study that found optimists live 15% longer than pessimists.
  • Sinclair explains his xenohormesis hypothesis: stressed plants produce polyphenols that signal adversity, activating longevity pathways like SIRT1. He recommends eating colorful vegetables like broccolini.
  • Sinclair says recent research challenges the old view that genetics determines only 10-15% of lifespan, suggesting the influence may be closer to 50%, but emphasizes at least half of lifespan remains under personal control.
  • Peter Diamandis frames genetics' role: lifestyle determines health for the first 70-80 years, genetics dominate from 80 to 110, and emerging therapeutics aim to overcome genetic limits.
  • Sinclair cites evidence that nattokinase is the most natural and powerful method to reverse atherosclerosis, while lowering LDL with drugs like PCSK9 inhibitors can also have reversal effects.
  • Sinclair details his lab's OSK gene therapy, showing it activates telomerase to lengthen telomeres and is being tested to reverse blindness from NAION, ALS, and macular degeneration in animal models.
  • Sinclair, prompted by his wife Serena, is now studying the mind-body connection, citing a paper showing brain nerve manipulation affects gut immunity and having a student research sensory nerve rejuvenation.
  • Sinclair advises investors in longevity biotech to prioritize team reputation and track record, cash runway, and clinical stage, noting capital deficiency is the number one cause of company mortality.
  • Sinclair references decades of work by Dr. Bhasin showing testosterone does not extend lifespan but prevents falls and supports metabolic health, while clarifying that hormone replacement for women is now considered safe.
  • Sinclair emphasizes the need to stress the body in an abundance-driven world, advocating for saunas, red light therapy, avoiding plastics, and improving indoor air and water quality.
HealthLongevityBiologyModelsAgents

Related Stories